Shire (SHPG) YoY Rev. per Sh. Growth : 3.63% (As of Sep. 2018)

View and export this data going back to 1998. Start your Free Trial

What is Shire YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Shire's YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2018 was 3.63%.

Shire's Revenue per Share for the three months ended in Sep. 2018 was $12.61.

Shire YoY Rev. per Sh. Growth Historical Data

The historical data trend for Shire's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shire YoY Rev. per Sh. Growth Chart

Shire Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

YoY Rev. per Sh. Growth

Get a 7-Day Free Trial

9.58

21.84

6.23

35.71

13.22

Shire Quarterly Data
	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18
YoY Rev. per Sh. Growth	Get a 7-Day Free Trial															5.77	10.89	5.38	4.09	3.63

Shire YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Shire's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2017 is calculated as:

	YoY Rev. per Sh. Growth (A: Dec. 2017 )
=	(Revenue per Share (A: Dec. 2017 )	-	Revenue per Share (A: Dec. 2016 ))	/	\| Revenue per Share (A: Dec. 2016 ) \|
=	(49.87	-	44.048)	/	\| 44.048 \|
=	13.22 %

Shire's YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2018 is calculated as:

	YoY Rev. per Sh. Growth (Q: Sep. 2018 )
=	(Revenue per Share (Q: Sep. 2018 )	-	Revenue per Share (Q: Sep. 2017 ))	/	\| Revenue per Share (Q: Sep. 2017 )) \|
=	(12.61	-	12.168)	/	\| 12.168 \|
=	3.63 %

Shire YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Shire's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Shire (SHPG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shire PLC (NAS:SHPG) » Definitions » YoY Rev. per Sh. Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.shire.com

Shire is a diversified, Ireland-based specialty drug firm. Shire has grown primarily through mergers and acquisitions, including the Transkaryotic Therapies acquisition in 2005, which established its genetic disease business with Replagal and Elaprase, and the merger with New River in 2007, which brought full rights to neuroscience drug Vyvanse. Shire completed the acquisition of ViroPharma (genetic diseases) in 2014, NPS Pharma (internal medicine) in 2015, and Baxalta (hematology, immunology, and oncology) and Dyax (genetic diseases) in 2016.

Executives

James H Cavanaugh

director

265 HOTHORPE LANE, VILLANOVA PA 19085